Clinical and Molecular Characteristics Associated with Survival in Advanced Melanoma Treated with Checkpoint Inhibitors

BACKGROUND: We performed meta-analysis to gather more evidence regarding clinical-molecular subgroups associated with better overall survival (OS) in advanced melanoma treated with checkpoint inhibitors. MATERIALS AND METHODS: We performed a systematic search of PubMed, Scopus, Cochrane Library, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Badami, Sunil, Upadhaya, Sunil, Velagapudi, Ravi Kanth, Mikkilineni, Pushyami, Kunwor, Ranju, Al Hadidi, Samer, Bachuwa, Ghassan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6077519/
https://www.ncbi.nlm.nih.gov/pubmed/30112001
http://dx.doi.org/10.1155/2018/6279871

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6077519/
https://www.ncbi.nlm.nih.gov/pubmed/30112001
http://dx.doi.org/10.1155/2018/6279871

Ejemplares similares